Skip to main content
. Author manuscript; available in PMC: 2013 May 9.
Published in final edited form as: Surgery. 2012 Aug;152(2):218–226. doi: 10.1016/j.surg.2012.05.037

Fig. 2.

Fig. 2

Proportion of patients dying within 30 days of hepatic surgery stratified by the presence or absence of metabolic syndrome. Although overall mortality was 3%, patients with metabolic syndrome were noted to have a greater mortality (5.9%) compared with patients without metabolic syndrome (2.2%; P < .001).